Related references
Note: Only part of the references are listed.Defending against a difficult clostridioides with a vaccine
Sahil Khanna
LANCET INFECTIOUS DISEASES (2021)
Isolation and Characterization of the Novel Phage JD032 and Global Transcriptomic Response during JD032 Infection of Clostridioides difficile Ribotype 078
Tinghua Li et al.
MSYSTEMS (2020)
Trends in US Burden of Clostridioides difficile Infection and Outcomes
Alice Y. Guh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Bacteriophage endolysins as a potential weapon to combatClostridioides difficileinfection
Shakhinur Islam Mondal et al.
GUT MICROBES (2020)
The Pfam protein families database in 2019
Sara El-Gebali et al.
NUCLEIC ACIDS RESEARCH (2019)
A Novel Bacteriophage Lysin-Human Defensin Fusion Protein Is Effective in Treatment of Clostridioides difficile Infection in Mice
Zhong Peng et al.
FRONTIERS IN MICROBIOLOGY (2019)
Contributions of Net Charge on the PlyC Endolysin CHAP Domain
Xiaoran Shang et al.
ANTIBIOTICS-BASEL (2019)
Probiotics and Clostridium Difficile: A Review of Dysbiosis and the Rehabilitation of Gut Microbiota
Ashish S. Kalakuntla et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2019)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
L. Clifford McDonald et al.
CLINICAL INFECTIOUS DISEASES (2018)
Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States
Dongmu Zhang et al.
CLINICAL INFECTIOUS DISEASES (2018)
Efficacy of an Optimised Bacteriophage Cocktail to Clear Clostridium difficile in a Batch Fermentation Model
Janet Y. Nale et al.
ANTIBIOTICS-BASEL (2018)
CDD/SPARCLE: functional classification of proteins via subfamily domain architectures
Aron Marchler-Bauer et al.
NUCLEIC ACIDS RESEARCH (2017)
Increasing Incidence of Multiply Recurrent Clostridium difficile Infection in the United States A Cohort Study
Gene K. Ma et al.
ANNALS OF INTERNAL MEDICINE (2017)
Bacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In Vivo
Janet Y. Nale et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Newly identified bacteriolytic enzymes that target a wide range of clinical isolates of Clostridium difficile
Krunal K. Mehta et al.
BIOTECHNOLOGY AND BIOENGINEERING (2016)
Clostridium difficile colitis: pathogenesis and host defence
Michael C. Abt et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Using a Novel Lysin To Help Control Clostridium difficile Infections
Qiong Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Function of the CRISPR-Cas System of the Human Pathogen Clostridium difficile (vol 6, e01112, 2015)
Pierre Boudry et al.
MBIO (2015)
Function of the CRISPR-Cas System of the Human Pathogen Clostridium difficile
Pierre Boudry et al.
MBIO (2015)
Treatment of recurrent Clostridium difficile infection: a systematic review
J. C. O'Horo et al.
INFECTION (2014)
Phage therapy-constraints and possibilities
Anders S. Nilsson
UPSALA JOURNAL OF MEDICAL SCIENCES (2014)
Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection
Casey M. Theriot et al.
NATURE COMMUNICATIONS (2014)
Clostridium difficile phages: Still difficult?
Katherine R. Hargreaves et al.
FRONTIERS IN MICROBIOLOGY (2014)
Both Fidaxomicin and Vancomycin Inhibit Outgrowth of Clostridium difficile Spores
Charlotte A. Allen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Novel Bacteriophage Lysin with Broad Lytic Activity Protects against Mixed Infection by Streptococcus pyogenes and Methicillin-Resistant Staphylococcus aureus
Daniel B. Gilmer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Is Fidaxomicin Worth the Cost? An Economic Analysis
Sarah M. Bartsch et al.
CLINICAL INFECTIOUS DISEASES (2013)
Novel avenues for Clostridium difficile infection drug discovery
Mario Zucca et al.
EXPERT OPINION ON DRUG DISCOVERY (2013)
Fidaxomicin: A Novel Macrocyclic Antibiotic Approved for Treatment of Clostridium difficile Infection
Anilrudh A. Venugopal et al.
CLINICAL INFECTIOUS DISEASES (2012)
Consequences of Clostridium difficile infection: understanding the healthcare burden
E. Bouza
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Bacteriophage endolysins as novel antimicrobials
Mathias Schmelcher et al.
FUTURE MICROBIOLOGY (2012)
The Clostridium difficile spo0A Gene Is a Persistence and Transmission Factor
Laura J. Deakin et al.
INFECTION AND IMMUNITY (2012)
Fecal microbiota transplantation in relapsing Clostridium difficile infection
Faith Rohlke et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2012)
Improving the Physical Realism and Structural Accuracy of Protein Models by a Two-Step Atomic-Level Energy Minimization
Dong Xu et al.
BIOPHYSICAL JOURNAL (2011)
Structure-Based Modification of a Clostridium difficile-Targeting Endolysin Affects Activity and Host Range
Melinda J. Mayer et al.
JOURNAL OF BACTERIOLOGY (2011)
Role of Net Charge on Catalytic Domain and Influence of Cell Wall Binding Domain on Bactericidal Activity, Specificity, and Host Range of Phage Lysins
Lieh Yoon Low et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Circoletto: visualizing sequence similarity with Circos
Nikos Darzentas
BIOINFORMATICS (2010)
Clostridium difficile in food-innocent bystander or serious threat?
J. S. Weese
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Clostridium difficile spore germination: an update
David A. Burns et al.
RESEARCH IN MICROBIOLOGY (2010)
Phage Lysin LysK Can Be Truncated to Its CHAP Domain and Retain Lytic Activity against Live Antibiotic-Resistant Staphylococci
Marianne Horgan et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2009)
Treatment of Clostridium difficile-Associated Disease
Daniel A. Leffler et al.
GASTROENTEROLOGY (2009)
Comparison of the Efficacy of a Hydrogen Peroxide Dry-Mist Disinfection System and Sodium Hypochlorite Solution for Eradication of Clostridium difficile Spores
F. Barbut et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Recent advances in Clostridium difficile-associated disease
T. Monaghan et al.
POSTGRADUATE MEDICAL JOURNAL (2009)
Molecular characterization of a Clostridium difficile bacteriophage and its cloned biologically active endolysin
Melinda J. Mayer et al.
JOURNAL OF BACTERIOLOGY (2008)
Germination of spores of Clostridium difficile strains, including isolates from a hospital outbreak of Clostridium difficile-associated disease (CDAD)
Daniel Paredes-Sabja et al.
MICROBIOLOGY-SGM (2008)
Recent advances in Clostridium difficile-associated disease
T. Monaghan et al.
GUT (2008)
Mutagenesis of a bacteriophage lytic enzyme PlyGBS significantly increases its antibacterial activity against group B streptococci
Qi Cheng et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2007)
The 1.6 A crystal structure of the catalytic domain of PlyB, a bacteriophage lysin active against Bacillus anthracis
Corrine J. Porter et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Emergence of Clostridium difficile-associated disease in North America and Europe
E. J. Kuijper et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Three-dimensional structure of the bacterial cell wall peptidoglycan
SO Meroueh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Structure and lytic activity of a Bacillus anthracis prophage endolysin
LY Low et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme
D Nelson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
